<SEC-DOCUMENT>0001279569-20-000613.txt : 20200427
<SEC-HEADER>0001279569-20-000613.hdr.sgml : 20200427
<ACCEPTANCE-DATETIME>20200424180341
ACCESSION NUMBER:		0001279569-20-000613
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20200424
FILED AS OF DATE:		20200427
DATE AS OF CHANGE:		20200424

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AURORA CANNABIS INC
		CENTRAL INDEX KEY:			0001683541
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38691
		FILM NUMBER:		20816413

	BUSINESS ADDRESS:	
		STREET 1:		500 - 10355 JASPER AVENUE
		CITY:			EDMONTON
		STATE:			A0
		ZIP:			T5J 1Y6
		BUSINESS PHONE:		604-362-5207

	MAIL ADDRESS:	
		STREET 1:		900 - 510 SEYMOUR STREET
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V6B 1V5
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>aurora_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>UNITED
STATES</B></FONT><BR>
<FONT STYLE="font-size: 14pt"><B>SECURITIES AND EXCHANGE COMMISSION</B></FONT><BR>
<B>Washington, D.C. 20549</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><B>FORM 6-K</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><B>REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: center"><B>RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">For the month of <B>April 2020</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">Commission File No. <B>001-38691</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><FONT STYLE="font-size: 24pt"><B>AURORA
CANNABIS INC.</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 70%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: center"><FONT STYLE="font-size: 24pt"></FONT><BR>
<FONT STYLE="font-size: 10pt">(Translation of registrant's name into English)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><B>500 - 10355 Jasper Avenue</B><BR>
<B>Edmonton, Alberta, T5J 1Y6, Canada</B></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 70%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: center"><B></B><BR>
(Address of principal executive office)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">Form 20-F &#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <B> Form
40-F&nbsp;&nbsp;&#9746;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Indicate by check mark if the registrant is submitting the
Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) &nbsp;&#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Indicate by check mark if the registrant is submitting the
Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7) &nbsp;&#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 12pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 4pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>SUBMITTED HEREWITH</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 8%; font: 12pt Times New Roman, Times, Serif; text-align: center; vertical-align: middle; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Exhibits</B></FONT></TD>
    <TD STYLE="width: 2%"></TD>
    <TD STYLE="width: 90%; font: 12pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Description&nbsp;</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt"><A HREF="ex991.htm">99.1</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: bold 13pt Arial, Helvetica, Sans-Serif; text-align: left; text-transform: uppercase"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; text-transform: none"><A HREF="ex991.htm">Information Notice - Consolidation of Shares</A></FONT></TD></TR>

</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"><B>AURORA CANNABIS INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">/s/ <I>Glen Ibbott</I></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 50%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0"><I></I><BR>
Glen Ibbott<BR>
Chief Financial Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Date:  April 24, 2020</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex991.htm
<DESCRIPTION>INFORMATION NOTICE - CONSOLIDATION OF SHARES
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Exhibit 99.1</B></FONT></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: center"><B>AURORA CANNABIS INC.<BR>
(the &ldquo;Corporation&rdquo;)</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: center"><B>INFORMATION NOTICE - CONSOLIDATION
OF SHARES</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: left"><B>TO INVESTORS:</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">After
careful consideration and pursuant to section 54(1) of the <I>Business Corporations Act </I>(British Columbia) (the &ldquo;<B>BCBCA</B>&rdquo;),
the board of directors of the Corporation (the &ldquo;<B>Board</B>&rdquo;) approved on April 12, 2020 a resolution to, among other
things, consolidate the share capital of the Corporation (the &ldquo;<B>Consolidation Resolution</B>&rdquo;). The Consolidation
Resolution authorized management of the Corporation to effect the consolidation (the &ldquo;<B>Consolidation</B>&rdquo;) of the
common shares of the Corporation (the &ldquo;<B>Common Shares</B>&rdquo;) on the basis of one (1) post-consolidation Common Share
for twelve (12) pre-consolidation Common Shares (the &ldquo;<B>Consolidation Ratio</B>&rdquo;) to be effective on or about May
11, 2020 (the &ldquo;<B>Effective Date</B>&rdquo;). Further, pursuant to section 83 of the <I>Business Corporations Act</I> (British
Columbia), each fractional Common Share remaining after completion of the Consolidation that is less than </FONT>half (&frac12;)
of a whole Common Share will be cancelled without consideration to the holders thereof and each fractional Common Share that is
at least half (&frac12;) of a whole Common Share will be increased to one whole Common Share.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify">The Corporation will send to registered
holders of Common Shares (the &ldquo;<B>Registered Holders</B>&rdquo;) a letter of transmittal (the &ldquo;<B>Letter of Transmittal</B>&rdquo;)
that may be used by such Registered Holders to exchange their pre-Consolidation Common Share certificates for certificates in the
capital of the Corporation representing the consolidated number of Common Shares. If a shareholder of the Corporation (a &ldquo;<B>Shareholder</B>&rdquo;)
holds his, her or its Common Shares with such a bank, broker or other nominee and if such Shareholder has any questions in this
regard, such Shareholder is encouraged to contact his, her or its nominee for further instructions, including obtaining physical
certificates representing post-Consolidation Common Shares.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 12pt 0; text-align: justify"><B>The Share Consolidation</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify">The Board believes, for the reasons listed
below, that a consolidation of the current number of outstanding Common Shares may be of benefit to the Corporation.</P>

<P STYLE="font: italic 10pt Arial, Helvetica, Sans-Serif; margin: 12pt 0; text-align: justify"><I>Reasons for the Consolidation</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify">On April 8, 2020, the Corporation received
notification from the New York Stock Exchange (the &ldquo;<B>NYSE</B>&rdquo;) that, as a result of its Common Share price falling
below an average of US$1.00 for a consecutive 30 trading-day period, it is not in compliance with one of the NYSE&rsquo;s continued
listing standards. The Corporation expects the Consolidation to restore compliance with the NYSE&rsquo;s continued listing standards.
In addition, the Consolidation may increase the trading price of the Common Shares, which the Board believes will enhance their
marketability and may increase the liquidity of the Common Shares if implemented at an appropriate time. The Board also believes
that the Consolidation could result in broader interest and demand from those institutional and other investors that have internal
guidelines and policies discouraging or prohibiting investments in lower priced securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify">Non-compliance with the NYSE price listing
standard does not affect the continued listing and trading of the Common Shares on the Toronto Stock Exchange (the &ldquo;<B>TSX</B>&rdquo;),
the Corporation&rsquo;s business operations or its reporting requirements to any regulatory authorities, nor does it breach or
cause an event of default under any of the Corporation&rsquo;s agreements with its lenders.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify">The Consolidation will be implemented
on the Effective Date with no further action required by registered holders of Common Shares. If the Board determines prior to
the Effective Date it is not in the best interests of the Corporation to complete the Consolidation, it will make such a determination
and promptly disseminate a public announcement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify">In proposing the Consolidation Ratio
in connection with the Consolidation, the Board has considered, among other things, factors such as:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The historical trading prices and trading volume of the Common Shares;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The prevailing trading price and trading volume of the Common Shares
and the anticipated impact of the Consolidation on the trading market(s) for the Common Shares;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The outlook for the trading price of the Common Shares;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Threshold prices of brokerage firms or institutional investors that
could impact their ability to invest or recommend investments in the Common Shares;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Advice received from the Corporation&rsquo;s financial and legal
advisors; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Prevailing general market and economic conditions.</FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Arial, Helvetica, Sans-Serif; margin: 12pt 0; text-align: justify"><I>Certain Risks Associated with
the Consolidation</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify">The effect of the Consolidation on the
per-share market price of the Common Shares cannot be predicted with any certainty, and the record of similar share consolidations
for corporations similar to the Corporation is varied. There can be no assurance that the total market capitalization of the Common
Shares of the Corporation (the aggregate value of all Common Shares at the then market price) immediately after the Consolidation
will be equal to or greater than the total market capitalization immediately before the Consolidation. In addition, there can be
no assurance that the per-share market price of the Common Shares following the Consolidation will remain higher than the per-share
market price of the Common Shares immediately before the Consolidation or equal or exceed the direct arithmetical result of the
Consolidation. Both the total market capitalization of the Corporation and the adjusted per-share market price of Common Shares
following the Consolidation may be lower than the Corporation&rsquo;s total market capitalization and per-share market price of
Common Shares before the Consolidation took effect. In addition, a decline in the market price of the Common Shares after the Consolidation
may result in a greater percentage decline than would occur in the absence of a Consolidation, and the liquidity of the Common
Shares could be adversely affected. Further, there can be no assurance that, if the Consolidation is implemented, the margin terms
associated with the purchase of Common Shares will improve or that the Corporation will be successful in receiving increased attention
from institutional investors. In addition to the above, the per-share market price of the Common Shares will continue to be based
on the Corporation&rsquo;s financial and operating results, the Corporation&rsquo;s available capital and liquidity resources,
the development of the Corporation&rsquo;s product pipeline, market conditions, including the general effect of the novel COVID-19
coronavirus on financial markets and the cannabis industry, the market perception of the cannabis industry, changes in laws and
regulations and other factors, which are unrelated to the numbers of Common Shares outstanding.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify">The Consolidation is subject to the satisfaction
of the requirements of the NYSE and the TSX.</P>

<P STYLE="font: italic 10pt Arial, Helvetica, Sans-Serif; margin: 12pt 0; text-align: justify"><I>Principal Effects of the Consolidation</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify">As of the date of this Information Notice,
on a pre-Consolidation basis, the Corporation had 1,313,494,990 Common Shares issued and outstanding and, in addition to Common
Shares issuable under the Corporation&rsquo;s equity compensation plans, the Corporation had the following securities issued and
outstanding:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">5,684,554 warrants expiring November 2, 2020, each exercisable for
one (1) Common Share (the &ldquo;<B>2020 Warrants</B>&rdquo;), pursuant to the warrant indenture between the Corporation and the
Computershare Trust Company of Canada, as warrant agent, dated November 2, 2017;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">6,173,835 warrants expiring August 9, 2023 (the &ldquo;<B>2023 Warrants</B>&rdquo;),
each exercisable for one (1) Common Share;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">164,467 warrants expiring August 22, 2024 (the &ldquo;<B>2024 Warrants</B>&rdquo;),
each exercisable for one (1) Common Share; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">USD$345,000,000 in 5.50% convertible debentures due 2024 (the &ldquo;<B>2024
Notes</B>&rdquo;) pursuant to the indenture between the Corporation and GLAS Trust Company LLC, as trustee, dated January 4, 2019.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify">Following the completion of the proposed
Consolidation, the number of Common Shares that would remain issued and outstanding would be 109,457,915, subject to adjustment
due to the elimination of fractional shares. The Corporation is also authorized to issue an unlimited number of Class &ldquo;A&rdquo;
Shares with a par value of $1.00 each and is authorized to issue an unlimited number of Class &ldquo;B&rdquo; Shares with a par
value of $5.00 each. There were no Class &ldquo;A&rdquo; Shares and no Class &ldquo;B&rdquo; Shares issued and outstanding as of
the date of this Information Notice.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify">Certain proportionate adjustments will
be made to outstanding warrants upon exercise thereof and to the 2024 Notes upon conversion thereof, in accordance with the terms
and conditions governing such securities and summarized below:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Holders of the 2020 Warrants will be required to exercise twelve
(12) warrants with an aggregate exercise price of $48.00 to receive one (1) Common Share following the Consolidation;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Holders of the 2023 Warrants will be required to exercise twelve
(12) warrants with an aggregate exercise price of $112.40 to receive one (1) Common Share following the Consolidation;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Holders of 2024 Warrants will be required to exercise twelve (12)
warrants with an aggregate exercise price of $116.04 to receive one (1) post-Consolidation Common Shares; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Holders of 2024 Notes will be entitled upon conversion in accordance
with terms of such notes to receive 11.5308 Common Shares for every $1,000 principal amount of 2024 Notes held.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify">As the Corporation currently has an unlimited
number of Common Shares authorized for issuance, the Consolidation will not have any effect on the number of Common Shares that
remain available for future issuances. The Common Shares reserved for issuance pursuant to the Corporation&rsquo;s Stock Option
Plan would also be consolidated on a proportionate basis. The Corporation&rsquo;s other share-based compensation schemes, the RSU
Plan and the DSU Plan, would have all such outstanding awards similarly consolidated.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify">The Consolidation may result in some
Shareholders owning &ldquo;odd lots&rdquo; of Common Shares on a post-Consolidation basis. Odd lots may be more difficult to sell,
or require greater transaction costs per Common Share to sell, than Common Shares in &ldquo;board lots&rdquo;. Brokerage commissions
and other costs of transactions in odd lots are often higher than the costs of transactions in &ldquo;roundlots&rdquo; of even
multiples of &ldquo;board lots&rdquo;.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify">The Consolidation will not give rise
to a capital gain or loss under the <I>Income Tax Act</I> (Canada) for a Shareholder who holds such Common Shares as capital property.
The adjusted cost base to the Shareholder of the post-Consolidation Common Shares immediately after the Consolidation will be equal
to the aggregate adjusted cost base to the Shareholder of the pre-Consolidation Common Shares immediately before the Consolidation.</P>

<P STYLE="font: italic 10pt Arial, Helvetica, Sans-Serif; margin: 12pt 0; text-align: justify"><I>Notice of Consolidation and Letter
of Transmittal</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify">Assuming the implementation of the Consolidation,
the Corporation or its registrar and transfer agent will give written notice thereof to all the Registered Shareholders and will
provide them with the Letter of Transmittal to be used for the purpose of surrendering such Registered Shareholders&rsquo; certificates
representing the pre-Consolidation Common Shares to the Corporation&rsquo;s registrar and transfer agent in exchange for new certificates
representing whole post-Consolidation Common Shares. After the Consolidation, certificates representing pre-Consolidation Common
Shares will (i) not constitute good delivery for the purposes of trades of post-Consolidation Common Shares; and (ii) be deemed
for all purposes to represent the number of post-Consolidation Common Shares to which the Registered Shareholder is entitled as
a result of the Consolidation. No delivery of a new certificate to a Registered Shareholder will be made until the Registered Shareholder
has surrendered his, her or its pre-Consolidation certificate(s).</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify">&nbsp;</P>

<P STYLE="font: italic 10pt Arial, Helvetica, Sans-Serif; margin: 12pt 0; text-align: justify"><I>Fractional Shares</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Pursuant
to section 83 of the BCBCA, each fractional Common Share remaining after completion of the Consolidation that is less than </FONT>half
(&frac12;) of a whole Common Share will be cancelled without consideration to the holders thereof and each fractional Common Share
that is at least half (&frac12;) of a whole Common Share will be increased to one (1) whole Common Share.</P>

<P STYLE="font: italic 10pt Arial, Helvetica, Sans-Serif; margin: 12pt 0; text-align: justify"><I>Percentage Shareholdings</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify">The Consolidation will not affect any
Shareholder&rsquo;s percentage ownership in the Corporation other than by the minimal effect of cancelling or rounding up fractional
Common Shares, even though such ownership will be represented by a smaller number of Common Shares. See &ldquo;The Share Consolidation
&ndash; Fractional Shares&rdquo;. Instead, the Consolidation will reduce proportionately the number of Common Shares held by all
Shareholders.</P>

<P STYLE="font: italic 10pt Arial, Helvetica, Sans-Serif; margin: 12pt 0; text-align: justify"><I>Effect on Non-Registered Holders</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify">Non-Registered Holders holding their
Common Shares through a bank, broker or other nominee should note that such banks, brokers or other nominees may have different
procedures for processing the proposed Consolidation than those that will be put in place by the Corporation for Registered Shareholders.
If you hold your Common Shares with such a bank, broker or other nominee and if you have any questions in this regard, you are
encouraged to contact your nominee.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify"><B>Forward Looking Information </B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify">This information notice includes statements
containing certain &ldquo;forward-looking information&rdquo; within the meaning of applicable securities law (&ldquo;<B>forward-looking
statements</B>&rdquo;). Forward-looking statements are frequently characterized by words such as &ldquo;plan&rdquo;, &ldquo;continue&rdquo;,
&ldquo;expect&rdquo;, &ldquo;project&rdquo;, &ldquo;intend&rdquo;, &ldquo;believe&rdquo;, &ldquo;anticipate&rdquo;, &ldquo;estimate&rdquo;,
&ldquo;may&rdquo;, &ldquo;will&rdquo;, &ldquo;potential&rdquo;, &ldquo;proposed&rdquo; and other similar words, or statements that
certain events or conditions &ldquo;may&rdquo; or &ldquo;will&rdquo; occur. These forward-looking statements are only predictions.
Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements
throughout this information notice. Forward-looking statements are based on the opinions, estimates and assumptions of management
in light of management&rsquo;s experience and perception of historical trends, current conditions and expected developments at
the date the statements are made, such as current and future market conditions, the current and future regulatory environment and
future approvals and permits. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that
management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance,
prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements, including
general business and economic conditions, changes in laws and regulations, product demand, changes in prices of required commodities,
competition and other risks, uncertainties and factors set out under the heading &ldquo;Risk Factors&rdquo; in the Corporation&rsquo;s
annual information form dated September 10, 2019 (the &ldquo;<B>AIF</B>&rdquo;) and filed with Canadian securities regulators available
on the Corporation&rsquo;s issuer profile on SEDAR at www.sedar.com. The Corporation cautions that the list of risks, uncertainties
and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are
urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned
not to place undue reliance on such information. The Corporation is under no obligation, and expressly disclaims any intention
or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise,
except as expressly required by applicable securities laws.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="RIGHT" STYLE="width: 50%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD ROWSPAN="4" STYLE="font: 9pt Arial, Helvetica, Sans-Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD ROWSPAN="4" STYLE="font: 9pt Arial, Helvetica, Sans-Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: blue"><FONT STYLE="color: Black"><B>AURORA
        CANNABIS INC.</B></FONT></P>
        <P STYLE="font: 7.5pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: blue"><FONT STYLE="color: Black"><B>&nbsp;</B></FONT></P>
        <P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: blue"><FONT STYLE="color: Black"><B>&nbsp;</B></FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 7.5pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>
        <P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="color: Black">By:</FONT></P></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="color: Black"><I>&nbsp;</I></FONT></P>
        <P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="color: Black"><I>{Signed}
        Michael Singer</I></FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 9pt Arial, Helvetica, Sans-Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; font: 9pt Arial, Helvetica, Sans-Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: Black"><B>Michael
    Singer</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 9pt Arial, Helvetica, Sans-Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 9pt Arial, Helvetica, Sans-Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: Black">Executive
    Chairman and Interim Chief Executive Officer</FONT></TD></TR>
</TABLE><BR STYLE="clear: both">
<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 7.5pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: justify"><B>&nbsp;</B></P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR>
</TABLE>





</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
